Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Nephrol ; 17(1): 140, 2016 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-27686684

RESUMO

BACKGROUND: Immunotactoid glomerulopathy (ITG) is a rare cause of proteinuria characterized by organized microtubular deposits in the glomerulus. ITG has been associated with underlying lymphoproliferative disorders and any renal impairment may be reversible with treatment of the concomitant hematologic malignancy. This case is the first reported in literature where diffuse large B cell lymphoma developed two years following the initial ITG diagnosis. CASE PRESENTATION: A 55-year-old woman with a history of well-controlled diabetes mellitus and thalassemia trait presented with proteinuria (830 mg/day) in 2010. Initially, she was managed with renin-angiotensin-aldosterone-system blockade. In 2012, the proteinuria worsened (4.3 g/day) and a renal biopsy showed immunotactoid glomerulopathy (Fig. 1). Despite extensive work up, no lymphoproliferative disorder was initially found. In January 2014, the patient presented with a soft-palate mass found on biopsy to be diffuse large B-cell lymphoma. She received 6 cycles of R-CHOP, 4 cycles of high dose methotrexate chemotherapy for CNS prophylaxis and 30 Gy of Intensity Modulated Radiation Therapy. Follow-up revealed complete remission of diffuse large B-cell lymphoma and resolution of proteinuria from the ITG. CONCLUSION: As we recognize that patients with ITG may develop hematopoietic neoplasms, close long-term monitoring is important. Moreover, treatment of the lymphoproliferative disorder can allow for complete remission of ITG.

2.
Med Mycol ; 50(2): 197-201, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21612561

RESUMO

We describe a case of disseminated Sporothrix schenckii infection in a man with underlying hairy cell leukemia. The immunological defects associated with this malignancy, as well as the management of refractory sporotrichosis are reviewed.


Assuntos
Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Leucemia de Células Pilosas/microbiologia , Sporothrix/isolamento & purificação , Esporotricose/complicações , Esporotricose/tratamento farmacológico , Triazóis/uso terapêutico , Adulto , Humanos , Perna (Membro)/patologia , Masculino , Pele/microbiologia , Pele/patologia , Esporotricose/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...